Bladder cancer mortality associated with arsenic in drinking water in Argentina

被引:332
作者
HopenhaynRich, C
Biggs, ML
Fuchs, A
Bergoglio, R
Tello, EE
Nicolli, H
Smith, AH
机构
[1] School of Public Health, University of California, Berkeley, CA
[2] Ctro. de Invest. Epidemiologicas, Academia Nacional de Medicina, Buenos Aires
[3] Univ. Nacional de Córdoba, Acad. de Cie. Medicas de Cordoba, Córdoba
[4] Univ. Nacional de Córdoba, Facultad de Ciencias Médicas, Córdoba
[5] INGEOQUI, Buenos Aires
[6] Claudia Hopenhayn-Rich, School of Public Health, University of California, Berkeley
关键词
Argentina; arsenic; bladder neoplasms; water pollutants; gender;
D O I
10.1097/00001648-199603000-00003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Inorganic arsenic (In-As) is known to be a human carcinogen, causing lung cancer by inhalation and skin cancer by ingestion. Ecologic studies in Taiwan have found a dose-response relation between ingestion of In-As from drinking water and bladder cancer, but questions have been raised concerning the validity and generalizability of the findings. Several areas of Argentina have had high exposures to arsenic from naturally contaminated drinking water, particularly the eastern region of the province of Cordoba. In this study, we investigated bladder: cancer mortality for the years 1986-1991 in Cordoba's 26 counties, using rates for all of Argentina as the standard for comparison. Bladder cancer standardized mortality ratios (SMRs) were consistently higher in counties with documented arsenic exposure. We grouped counties into low-, medium-, and high exposure categories; the corresponding SMRs [with 95% confidence intervals (CI)] were 0.80 (95% CI = 0.66-0.96), 1.42 (95% CI = 1.14-1.74), and 2.14 (95% CI = 1.78-2.53) for men, and 1.21 (95% CI = 0.85-1.64), 1.58 (95% CI = 1.01-2.35), and 1.82 (95% CI = 1.19-2.64) for women. The clear trends found in a population with different genetic composition and a high-protein diet support the findings in Taiwan.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 53 条
[1]  
ARROYOMENESES A, 1991, PRIMERA JORNADA ARSE, P35
[2]  
Astolfi EAN, 1982, HIDROARSENICISMO CRO
[3]  
AYERZA A, 1917, B ACAD NAC MED, P1
[4]   ARSENIC INGESTION AND INTERNAL CANCERS - A REVIEW [J].
BATES, MN ;
SMITH, AH ;
HOPENHAYNRICH, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) :462-476
[5]  
BERGOGLIO R M, 1964, Prensa Med Argent, V51, P994
[6]   EPIDEMIOLOGICAL ASSOCIATIONS BETWEEN ARSENIC AND CANCER IN ARGENTINA [J].
BESUSCHIO, SC ;
DESANZO, ACP ;
CROCI, M .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1980, 2 (01) :41-55
[7]  
Biagini RE, 1972, SEMANA MED, V141, P812, DOI DOI 10.1016/J.SCITOTENV.2007.02.037
[8]  
BIAGINI RE, 1972, SEMANA MED, V140, P308
[9]  
BIAGINI RE, 1975, MED CUTAN IBERO LATI, P423
[10]  
BIAGINI RE, 1983, ARCH ARGENT DERMATOL, V33, P193